Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon.
Valkema MJ, Spaander MCW, Boonstra JJ, van Dieren JM, Hazen WL, Erkelens GW, Holster IL, van der Linden A, van der Linde K, Oostenbrug LE, Quispel R, Schoon EJ, Siersema PD, Doukas M, Eyck BM, van der Wilk BJ, van der Sluis PC, Wijnhoven BPL, Lagarde SM, van Lanschot JJB. Valkema MJ, et al. Among authors: oostenbrug le. Br J Surg. 2023 Sep 6;110(10):1381-1386. doi: 10.1093/bjs/znad211. Br J Surg. 2023. PMID: 37418342 Free PMC article.
Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial.
Noordman BJ, Wijnhoven BPL, Lagarde SM, Boonstra JJ, Coene PPLO, Dekker JWT, Doukas M, van der Gaast A, Heisterkamp J, Kouwenhoven EA, Nieuwenhuijzen GAP, Pierie JEN, Rosman C, van Sandick JW, van der Sangen MJC, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Lanschot JJB; SANO-study group. Noordman BJ, et al. BMC Cancer. 2018 Feb 6;18(1):142. doi: 10.1186/s12885-018-4034-1. BMC Cancer. 2018. PMID: 29409469 Free PMC article.
Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.
van der Wilk BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, Nieuwenhuijzen GAP, Sosef MN, van Berge Henegouwen MI, Lagarde SM, Spaander MCW, Valkema R, Biermann K, Wijnhoven BPL, van der Gaast A, van Lanschot JJB, Doukas M, Nikkessen S, Luyer M, Schoon EJ, Roef MJ, van Lijnschoten I, Oostenbrug LE, Riedl RG, Gisbertz SS, Krishnadath KK, Bennink RJ, Meijer SL; Collaborators:. van der Wilk BJ, et al. Among authors: oostenbrug le. Ann Surg. 2021 Dec 1;274(6):1009-1016. doi: 10.1097/SLA.0000000000003636. Ann Surg. 2021. PMID: 31592898
Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial.
van der Wilk BJ, Eyck BM, Doukas M, Spaander MCW, Schoon EJ, Krishnadath KK, Oostenbrug LE, Lagarde SM, Wijnhoven BPL, Looijenga LHJ, Biermann K, van Lanschot JJB. van der Wilk BJ, et al. Among authors: oostenbrug le. Br J Surg. 2020 Dec;107(13):1791-1800. doi: 10.1002/bjs.11760. Epub 2020 Aug 5. Br J Surg. 2020. PMID: 32757307 Free PMC article. Clinical Trial.
Predictive value of endoscopic esophageal findings for residual esophageal cancer after neoadjuvant chemoradiotherapy.
van der Bogt RD, van der Wilk BJ, Nikkessen S, Krishnadath KK, Schoon EJ, Oostenbrug LE, Siersema PD, Vleggaar FP, Doukas M, van Lanschot JJB, Spaander MCW. van der Bogt RD, et al. Among authors: oostenbrug le. Endoscopy. 2021 Nov;53(11):1098-1104. doi: 10.1055/a-1362-9375. Epub 2021 Mar 2. Endoscopy. 2021. PMID: 33652496 Clinical Trial.
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
Noordman BJ, Spaander MCW, Valkema R, Wijnhoven BPL, van Berge Henegouwen MI, Shapiro J, Biermann K, van der Gaast A, van Hillegersberg R, Hulshof MCCM, Krishnadath KK, Lagarde SM, Nieuwenhuijzen GAP, Oostenbrug LE, Siersema PD, Schoon EJ, Sosef MN, Steyerberg EW, van Lanschot JJB; SANO study group. Noordman BJ, et al. Among authors: oostenbrug le. Lancet Oncol. 2018 Jul;19(7):965-974. doi: 10.1016/S1470-2045(18)30201-8. Epub 2018 Jun 1. Lancet Oncol. 2018. PMID: 29861116
Endoscopic ultrasound and fine-needle aspiration for the detection of residual nodal disease after neoadjuvant chemoradiotherapy for esophageal cancer.
van der Bogt RD, van der Wilk BJ, Poley JW, Krishnadath KK, Schoon EJ, Oostenbrug LE, Siersema PD, Vleggaar FP, Bruno MJ, Biermann K, van Lanschot JJB, Spaander MCW. van der Bogt RD, et al. Among authors: oostenbrug le. Endoscopy. 2020 Mar;52(3):186-192. doi: 10.1055/a-1065-1759. Epub 2019 Dec 9. Endoscopy. 2020. PMID: 31816658
Bite-on-bite biopsies for the detection of residual esophageal cancer after neoadjuvant chemoradiotherapy.
van der Bogt RD, van der Wilk BJ, Oudijk L, Schoon EJ, van Lijnschoten G, Corporaal S, Nieken J, Siersema PD, Bisseling TM, van der Post RS, Quispel R, van Tilburg A, Oostenbrug LE, Riedl RG, Hol L, Kliffen M, Nikkessen S, Eyck BM, van Lanschot JJB, Doukas M, Spaander MCW. van der Bogt RD, et al. Among authors: oostenbrug le. Endoscopy. 2022 Dec;54(12):1131-1138. doi: 10.1055/a-1846-1025. Epub 2022 Jun 3. Endoscopy. 2022. PMID: 35668664 Clinical Trial.
42 results